Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials - Concepedia

Concepedia

Publication | Closed Access

Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials

54

Citations

16

References

2024

Year

Xavier Montalbán, Patrick Vermersch, Douglas L. Arnold, Amit Bar‐Or, Bruce Cree, Anne H. Cross, Eva Havrdová, Ludwig Kappos, Olaf Stüve, Heinz Wiendl,

The Lancet Neurology

Neurological ProgressClinical TrialsNeurologyMultiple SclerosisMedicineNeuroimmunology

References

	Year	Citations

Page 1